Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jim Birchenough is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/2024 | SGMO | Buy Now | Sangamo Therapeutics | $0.84 | 138.89% | Jim Birchenough61% | $3 → $2 | Maintains | Equal-Weight | Get Alert |
| 03/13/2024 | RGLS | Buy Now | Regulus Therapeutics | $1.35 | 122.22% | Jim Birchenough61% | $2 → $3 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | CRSP | Buy Now | CRISPR Therapeutics | $40.92 | 71.07% | Jim Birchenough61% | $55 → $70 | Maintains | Equal-Weight | Get Alert |
| 11/06/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.84 | 19.45% | Jim Birchenough61% | → $1 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Jim Birchenough61% | $66 → $68.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/25/2022 | MEIP | Buy Now | MEI Pharma | $2.33 | -14.16% | Jim Birchenough61% | $260 → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/10/2022 | TPTX | Buy Now | Turning Point | — | — | Jim Birchenough61% | $120 → $85 | Maintains | Overweight | Get Alert |
| 02/09/2022 | ZYME | Buy Now | Zymeworks | $12.73 | 277.06% | Jim Birchenough61% | $56 → $48 | Maintains | Overweight | Get Alert |
| 09/22/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.29 | 2272.88% | Jim Birchenough61% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/28/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | $4 → $14 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/17/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | $2 → $4 | Maintains | Equal-Weight | Get Alert |
| 03/04/2021 | FATE | Buy Now | Fate Therapeutics | $0.90 | 14317.21% | Jim Birchenough61% | $84 → $130 | Maintains | Overweight | Get Alert |
| 02/22/2021 | PGEN | Buy Now | Precigen | $1.70 | 723.53% | Jim Birchenough61% | → $14 | Initiates | → Overweight | Get Alert |
| 02/02/2021 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Jim Birchenough61% | — | Initiates | → Overweight | Get Alert |
| 02/01/2021 | MRNA | Buy Now | Moderna | $33.78 | 329.18% | Jim Birchenough61% | $129 → $145 | Maintains | Equal-Weight | Get Alert |
| 12/07/2020 | CRSP | Buy Now | CRISPR Therapeutics | $40.92 | 254.35% | Jim Birchenough61% | → $145 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/23/2020 | MRNA | Buy Now | Moderna | $33.78 | 172.31% | Jim Birchenough61% | → $92 | Initiates | → Equal-Weight | Get Alert |
| 11/11/2020 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Jim Birchenough61% | → $34 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/30/2020 | BLCM | Buy Now | Bellicum Pharmaceuticals | — | — | Jim Birchenough61% | → $4.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/29/2020 | GILD | Buy Now | Gilead Sciences | $107.24 | -41.25% | Jim Birchenough61% | $69 → $63 | Maintains | Equal-Weight | Get Alert |
| 09/14/2020 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/07/2020 | RNA | Buy Now | Avidity Biosciences | $31.86 | — | Jim Birchenough61% | — | Initiates | → Overweight | Get Alert |
| 06/29/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | $146 → $46 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/25/2020 | QURE | Buy Now | uniQure | $14.21 | 294.09% | Jim Birchenough61% | → $56 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/26/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.70 | 15.83% | Jim Birchenough61% | → $734 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/18/2020 | IMV | Buy Now | IMV | — | — | Jim Birchenough61% | $25 → $85 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/13/2020 | TPTX | Buy Now | Turning Point | — | — | Jim Birchenough61% | $62 → $76 | Maintains | Overweight | Get Alert |
| 05/12/2020 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | $1.5 → $1 | Maintains | Equal-Weight | Get Alert |
| 04/23/2020 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | $34 → $41 | Maintains | Overweight | Get Alert |
| 04/20/2020 | GILD | Buy Now | Gilead Sciences | $107.24 | -18.87% | Jim Birchenough61% | → $87 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.70 | -31.36% | Jim Birchenough61% | $370 → $435 | Maintains | Equal-Weight | Get Alert |
| 03/26/2020 | CYAD | Buy Now | Celyad Oncology | — | — | Jim Birchenough61% | $44 → $20 | Maintains | Overweight | Get Alert |
| 03/13/2020 | KZR | Buy Now | Kezar Life Sciences | $5.55 | 224.32% | Jim Birchenough61% | $300 → $180 | Maintains | Overweight | Get Alert |
| 03/11/2020 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Jim Birchenough61% | $105 → $35 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/04/2020 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | $2.5 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 01/21/2020 | IMV | Buy Now | IMV | — | — | Jim Birchenough61% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/15/2020 | ZYME | Buy Now | Zymeworks | $12.73 | 355.62% | Jim Birchenough61% | $48 → $58 | Maintains | Overweight | Get Alert |
| 12/17/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | $120 → $146 | Maintains | Overweight | Get Alert |
| 12/09/2019 | FATE | Buy Now | Fate Therapeutics | $0.90 | 2561.64% | Jim Birchenough61% | → $24 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/06/2019 | FATE | Buy Now | Fate Therapeutics | $0.90 | 1674.43% | Jim Birchenough61% | $24 → $16 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/07/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 09/30/2019 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | $14 → $16 | Maintains | Market Perform | Get Alert |
| 09/04/2019 | TPTX | Buy Now | Turning Point | — | — | Jim Birchenough61% | $53 → $62 | Maintains | Outperform | Get Alert |
| 07/15/2019 | GILD | Buy Now | Gilead Sciences | $107.24 | -17.94% | Jim Birchenough61% | $68 → $88 | Upgrade | Market Perform → Outperform | Get Alert |
| 06/03/2019 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Jim Birchenough61% | $35 → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/13/2019 | TPTX | Buy Now | Turning Point | — | — | Jim Birchenough61% | → $53 | Initiates | → Outperform | Get Alert |
| 05/03/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 04/12/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | $99 → $104 | Maintains | Market Perform | Get Alert |
| 03/19/2019 | RGLS | Buy Now | Regulus Therapeutics | $1.35 | 11.11% | Jim Birchenough61% | $60 → $15 | Maintains | Market Perform | Get Alert |
| 03/15/2019 | QURE | Buy Now | uniQure | $14.21 | 533.36% | Jim Birchenough61% | $65 → $90 | Maintains | Outperform | Get Alert |
| 02/12/2019 | GILD | Buy Now | Gilead Sciences | $107.24 | -36.59% | Jim Birchenough61% | $89 → $68 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/18/2019 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | $44 → $18 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/12/2018 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/10/2018 | CRSP | Buy Now | CRISPR Therapeutics | $40.92 | 58.85% | Jim Birchenough61% | → $65 | Initiates | → Outperform | Get Alert |
| 09/24/2018 | AGTC | Buy Now | Applied Genetic Tech | — | — | Jim Birchenough61% | $20 → $6 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/06/2018 | RGLS | Buy Now | Regulus Therapeutics | $1.35 | -25.93% | Jim Birchenough61% | $180 → $120 | Maintains | Market Perform | Get Alert |
| 06/28/2018 | ARRY | Buy Now | Array Technologies | $5.58 | 491.44% | Jim Birchenough61% | $31 → $33 | Maintains | Outperform | Get Alert |
| 06/06/2018 | MEIP | Buy Now | MEI Pharma | $2.33 | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/04/2018 | ZYME | Buy Now | Zymeworks | $12.73 | 190.65% | Jim Birchenough61% | $20 → $37 | Maintains | Outperform | Get Alert |
| 06/04/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Jim Birchenough61% | $13 → $10 | Maintains | Market Perform | Get Alert |
| 06/04/2018 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | $25 → $31 | Maintains | Outperform | Get Alert |
| 05/17/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/16/2018 | QURE | Buy Now | uniQure | $14.21 | 230.75% | Jim Birchenough61% | → $47 | Initiates | → Outperform | Get Alert |
| 05/11/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 04/12/2018 | BLCM | Buy Now | Bellicum Pharmaceuticals | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/19/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/27/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | $27 → $20 | Maintains | Market Perform | Get Alert |
| 02/27/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/31/2018 | BLCM | Buy Now | Bellicum Pharmaceuticals | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/16/2018 | GILD | Buy Now | Gilead Sciences | $107.24 | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/11/2017 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/05/2017 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/18/2017 | IMDZ | Buy Now | Immune Design | — | — | Jim Birchenough61% | $29 → $10 | Maintains | Market Perform | Get Alert |
| 10/12/2017 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/04/2017 | DMTX | Buy Now | Dimension Therapeutics | — | — | Jim Birchenough61% | $9 → $6 | Maintains | Market Perform | Get Alert |
| 09/22/2017 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | $265 → $95 | Maintains | Market Perform | Get Alert |
| 09/21/2017 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/08/2017 | AKCA | Buy Now | Akcea Therapeutics | — | — | Jim Birchenough61% | → $27 | Initiates | → Outperform | Get Alert |
| 03/17/2017 | LBIO | Buy Now | Longevity Biomedical | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 03/17/2017 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.29 | — | Jim Birchenough61% | — | Initiates | → Market Perform | Get Alert |
| 03/08/2017 | BLCM | Buy Now | Bellicum Pharmaceuticals | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 02/22/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 02/22/2017 | KITE | Buy Now | Kite Pharma | — | — | Jim Birchenough61% | — | Initiates | → Market Perform | Get Alert |
| 01/30/2017 | RGLS | Buy Now | Regulus Therapeutics | $1.35 | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/12/2016 | TSO | Buy Now | Tesoro | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/23/2016 | PRXL | Buy Now | Parexel International | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/01/2016 | TMH | Buy Now | Team Health Holdings, Inc. Team Health Holdings, Inc. | $53.30 | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/25/2016 | SYRG | Buy Now | Synergy Resources Corporation Common Stock | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 10/12/2016 | NMBL | Buy Now | Nimble Storage, Inc. Common Stock | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 09/13/2016 | AGTC | Buy Now | Applied Genetic Tech | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/29/2016 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/21/2016 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/15/2016 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/05/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/04/2015 | RGLS | Buy Now | Regulus Therapeutics | $1.35 | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 12/04/2015 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/04/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Jim Birchenough61% | — | Assumes | → Outperform | Get Alert |
| 12/04/2015 | AGTC | Buy Now | Applied Genetic Tech | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 12/04/2015 | ICPT | Buy Now | Intercept Pharma | — | — | Jim Birchenough61% | — | Initiates | → Market Perform | Get Alert |
| 12/04/2015 | FATE | Buy Now | Fate Therapeutics | $0.90 | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 03/24/2015 | MEIP | Buy Now | MEI Pharma | $2.33 | — | Jim Birchenough61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/06/2015 | MEIP | Buy Now | MEI Pharma | $2.33 | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 01/07/2015 | IMMU | Buy Now | Immunomedics | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 08/18/2014 | IMDZ | Buy Now | Immune Design Corp | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 10/14/2013 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 05/09/2013 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 12/20/2012 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 12/20/2012 | ARRY | Buy Now | Array Technologies | $5.58 | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
| 12/20/2012 | ARRY | Buy Now | Array Technologies | $5.58 | — | Jim Birchenough61% | — | Initiates | → Outperform | Get Alert |
